Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Kevin M. Squires, M.Ed., B.S.
University of Pittsburgh
Poster(s):
(2183) Porin Mutations Potentiate the
in Vitro
Synergy of Meropenem-Vaborbactam (MVB), but not Ceftazidime-Avibactam (CZA) in Combination with Other Antibiotics against KPC-producing
Klebsiella Pneumoniae
(KPC-
Kp
)
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2185)
In vitro
activity of aztreonam-avibactam (ATM-AVI), cefiderocol (FDC), and cefepime-taniborbactam (FEP-TAN) against multi-species, NDM-producing
Enterobacterales
causing a local outbreak
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2186)
Treatment-emergent resistance to ceftazidime-avibactam (CZA) is more common than ceftolozane-tazobactam (CT) among patients infected with multidrug-resistant (MDR)
Pseudomonas aeruginosa
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
